Adiponectin and leptin in African Americans

Obesity

Volumn 16, Issue 2, 2008, Pages 428-434

  Considine, Robert V ^a   Premkumar, Ahalya ^b   Reynolds, James C ^b   Sebring, Nancy G ^b   Ricks, Madia ^c   Sumner, Anne E ^c  

^a INDIANA UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN;

ADIPOSE TISSUE; ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD; ETHNOLOGY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; REGRESSION ANALYSIS; SEXUAL DEVELOPMENT; SUBCUTANEOUS FAT;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; AFRICAN AMERICANS; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; SEX CHARACTERISTICS; SUBCUTANEOUS FAT;

EID: 39449105756     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.80     Document Type: Article

References (62)

1. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006;444:875-880.
2. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846.
3. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006;444:847-853.
4. Kuk JL, Katzmarzyk PT, Nichaman MZ et al. Visceral fat is an independent predictor of all-cause mortality in men. Obesity 2006;14:336-341.
5. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887.
6. Bergman RN, Kim SP, Catalano KJ et al. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity 2006;14(Suppl 1):S16-S19.
7. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001;29:72-75.
8. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
9. Saad MF, Rewers M, Selby J et al. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension 2004;43:1324-1331.
10. Ferdinand KC. Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol 2006;97:A12-A19.
11. Conway JM, Yanovski SZ, Avila NA, Hubbard VS. Visceral adipose tissue differences in black and white women Am J Clin Nutr 1995;61:765-771.
12. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race Metabolism 1996;45:1119-1124.
13. Hill JO, Sidney S, Lewis CE et al. Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study Am J Clin Nutr 1999:69:381-387.
14. Perry AC, Applegate EB, Jackson ML et al. Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables. J Appl Physiol 2000;89:636-643.
15. Lovejoy JC, Smith SR, Rood JC. Comparison of regional fat distribution and health risk factors in middle-aged white and African American women: the Healthy Transitions Study. Obes Res 2001;9:10-16.
16. Ryan AS, Nicklas BJ, Berman DM. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women. Obesity Res 2002;10:336-344.
17. Kanaley JA, Giannopoulou I, Tillapaugh-Fay G, Nappi JS, Ploutz-Snyder LL. Racial differences in subcutaneous and visceral fat distribution in postmenopausal black and white women. Metabolism 2003;52:186-191.
18. Williams LB, Fawcett RL, Waechter AS et al. Leptin production in adipocytes from morbidly obese subjects: stimulation by dexamethasone, inhibition with troglitazone and influence of gender. J Clin Endo Metab 2000;85:2678-2684.
19. Motoshima H, Wu X, Sinha MK et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002;87:5662-5667.
20. Trujillo ME, Scherer PE. Adiponectin- journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Int Med 2005;257:167-175.
21. Undsay RS, Funahashi T, Hanson RL et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002:360:57-58.
22. Snehalatha C, Mukesh B, Simon M et al. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003:26:3226-3229.
23. Duncan BB, Schmidt MI, Pankow JS et al. Adiponectin and the development of type 2 diabetes. The atherosclerosis risk in communities study. Diabetes 2004;53:2473-2478.
24. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-469.
25. Ryan AS, Berman DM, Nicklas BJ et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003;26:2383-2388.
26. Park KG, Park KS, Kim MJ et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004;63:135-142.
27. Cote M, Mauriege P, Bergeron J et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 2006;90:1434-1439.
28. Arner P. Insulin resistance in type 2 diabetes-role of the adipokines. Curr Mol Med 2005;5:333-339.
29. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997;389:374-377.
30. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73-76.
31. Ebihara K, Ogawa Y, Masuzaki H et al. Transgenic overexpression of leptin rescues insulin resistance and diabetes In a mouse model of lipatrophic diabetes. Diabetes 2001;50:1440-1448.
32. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996;45:1455-1462.
33. Van Harmelen V, Reynisdotir S, Eriksson P et al. Leptin secretion from subcutaneous and visceral adipose tissue of women. Diabetes 1998;47:913-917.
34. Halleux CM, Takahashi M, Delporte ML et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001;288:1102-1107.
35. Hoffstedt J, Arvidsson E, Sjolin E, Wahlen K, Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 2004;89:1391-1396.
36. Utrialnen T, Malmstrom R, Makimattila S, Yki-Jarvinen H. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4h in normal subjects. Diabetes 1996;45:1364-1366.
37. Saad MF, Khan A, Sharma A et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes 1998;47:544-549.
38. Considine RV, Cooksey RC, Williams LB et al. Hexosamines regulate leptin production in human subcutaneous adipocytes. J Clin Endo Metab 2000;85:3551-3556.
39. Haffner SM, D'Agostino R, Saad MF et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 1996;45:742-748.
40. Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003;52:2490-2496.
41. Tulloch-Reid MK, Hanson RL, Sebring NG et al. Both subcutaneous and visceral adipose tissue correlate highly with insulin resistance in African Americans. Obes Res 2004;12:1352-1359.
42. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
43. Mertens I, Ballaux D, Funahashi T et al. Inverse relationship between plasminogen activator inhibitor-1 activity and adiponectin in overweight and obese women. Thromb Haemost 2005;94:1190-1195.
44. Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA. Adiponectin is lower among African Americans and Is independently related to insulin sensitivity in children and adolescents. Diabetes 2005;54:2772-2778.
45. Lee SJ, Gungor N, Bacha F, Arslanian SA. Racial differences in adiponectin in youth. Diabetes Care 2006;29:51-56.
46. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vase Biol 2004;24:29-33.
47. Yu JG, Javorschi S, Hevener AL et al. The effect of thiazolldinediones on plasma adiponectin levels In normal, obese, and type 2 diabetic subjects. Diabetes 2002;51:2968-2974.
48. Mohlig M, Wegewitz U, Osterhoff M et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res 2002;34:655-658.
49. Brame LA, Considine RV, Yamauchi M, Baran AD, Mather KJ. Insulin and endothelin In the acute regulation of adiponectin in vivo in humans. Obesity Res 2005;13:582-588.
50. Hotta K, Funahashi T, Bodkin NL et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001:50:1126-1133.
51. Nishizawa H, Shimomura I, Kishida K et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51:2734-2741.
52. Xu A, Chan KW, Hoo RL et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005;280:18073-18080.
53. Statnick MA, Beavers LS, Conner LJ et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 2000;1:81-88.
54. Lihn AS, Bruun JM, He G et al. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004;219:9-15.
55. Degawa-Yamauchi M, Moss KA, Bovenkerk JE et al. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 2005;13:662-669.
56. Sumner AE, Falkner B, Kushner H, Considine RV. Relationship of leptin concentration to gender, menopause, age, diabetes, and fat mass in African Americans. Obes Res 1998;6:128-133.
57. Rosenbaum M, Leibel RL Clinical review 107: role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin. J Clin Endocrinol Metab 1999;84:1784-1789.
58. Degawa-Yamauchi M, Dilts JR, Bovenkerk JE et al. Lower serum adiponectin levels in African-American boys. Obes Res 2003;11:1384-1390.
59. Woo JG, Dolan LM, Daniels SR, Goodman E, Martin LJ. Adolescent sex differences in adiponectin are conditional on pubertal development and adiposity. Obesity Res 2005;13:2095-2101.
60. Steffes MW, Gross MD, Schreiner PJ et al. Serum adiponectin in young adults-interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 2004;14:492-498.
61. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism 2004;53:1-3.
62. Ukkola O, Santaniemi M, Rankinen T et al. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann Med 2005;37:141-150.